Quarterly report pursuant to Section 13 or 15(d)

Schedule of Warrant Liability (Details)

v3.23.1
Schedule of Warrant Liability (Details)
 3 Months Ended 9 Months Ended
Sep. 30, 2022
$ / shares
shares
Sep. 30, 2022
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Initial Grants 190,479,262 225,792,614
Outstanding shares, ending 17,011,065 17,011,065
Exercises (82,260,699) (180,585,391)
Outstanding shares, beginning 99,271,764 197,596,456
Outstanding shares, ending 17,011,065 17,011,065
June [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Exercise Price | $ / shares $ 3.3000 [1] $ 3.3000 [1]
Initial Grants 29,893,175 29,893,175
Outstanding shares, ending 115,800 115,800
Exercises (20,270,406)
Outstanding shares, beginning 115,800 20,386,206
Outstanding shares, ending 115,800 115,800
September A [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Exercise Price | $ / shares $ 9.0000 [1] $ 9.0000 [1]
Initial Grants 21,600,000 21,600,000
Outstanding shares, ending 6,600,000 6,600,000
Exercises (15,000,000)
Outstanding shares, beginning 6,600,000 21,600,000
Outstanding shares, ending 6,600,000 6,600,000
November [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Exercise Price | $ / shares $ 4.5270 [1] $ 4.5270 [1]
Initial Grants 16,200,000 16,200,000
Outstanding shares, ending 1,200,000 1,200,000
Exercises (14,500,000) (15,000,000)
Outstanding shares, beginning 15,700,000 16,200,000
Outstanding shares, ending 1,200,000 1,200,000
December [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Exercise Price | $ / shares $ 3.2653 [1] $ 3.2653 [1]
Initial Grants 122,786,087 122,786,087
Outstanding shares, ending 9,095,265 9,095,265
Exercises (67,760,699) (113,690,822)
Outstanding shares, beginning 76,855,964 122,786,087
Outstanding shares, ending 9,095,265 9,095,265
July [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Exercise Price | $ / shares   $ 2.6550 [1]
Initial Grants   35,313,352
Outstanding shares, ending
Exercises   (16,624,163)
Outstanding shares, beginning   16,624,163
Outstanding shares, ending
[1] Based on Exercise Price as of the initial grant; the above disclosure discusses modifications under specific Warrant Exchange Agreements.